ICOIconovo AB (publ)
1.175SEK-0.84%Mkt Cap: 10.81M $P/E:

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler…

Key Statistics

Company
Market Cap10.81M $
Enterprise Value6.60M $
Revenue (TTM)1.32M $
Gross Profit1.10M $
Net Income (TTM)-4.15M $
Revenue/Share0.0254 USD
Last Price1.175 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.08
PEG
EV/EBITDA-1.80
EV/Revenue4.99
P/S8.24
P/B0.72
EPS (TTM)-0.71
EPS (Forward)-1.10
52W Range
0.870016% of range2.790
52W High2.790 SEK
52W Low0.8700 SEK
Profitability
Gross Margin1042.65%
Oper. Margin-188.10%
EBITDA Margin-277.05%
Profit Margin-3925.50%
ROE-36.77%
ROA-33.08%
Growth
Revenue Growth-14.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-3.05M $
CapEx (TTM)1.35M $
FCF Margin-197.18%
FCF Yield-24.13%
Net Debt-4.17M $
Net Debt/EBITDA1.14
Balance Sheet
Debt/Equity0.03
Current Ratio3.70
Quick Ratio3.70
Book Value/Sh1.640 SEK
Cash/Share0.5120 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)0.8000 SEK
Upside (mean)-31.9%
Target Range0.8000 SEK0.8000 SEK
# Analysts1
Ownership
Shares Out.96.17M
Float92.60M
Insiders47.05%
Institutions35.90%
Technical
SMA 501.066 (+10.3%)
SMA 2001.162 (+1.1%)
Beta0.39
S&P 52W Chg18.16%
Avg Vol (30d)58.04K
Avg Vol (10d)40.69K
Technical Indicators
RSI (14)63.3
MACD0.0217
MACD Signal-0.0065
MACD Hist.+0.0282
BB Upper1.180 SEK
BB Middle1.019 SEK
BB Lower0.8573 SEK
BB Width31.68%
ATR (14)0.0635 SEK
Vol Ratio (20d)4.51x